Legence (LGN.US) Price Target 2026/2027: 95% Upside – Rating and Stock Analysis
Legence Price Target 2026: Analysts See 94% Upside
The average price target for Legence is $102.53. This price target represents the analysts' view of the stock price over the next 12 months. The stock may be undervalued, because the price target is higher than the current price. The stock is 93.56% below the target, which can point to potential returns within the next 12 months if the analysts' view proves right. Also consider the stock's valuation ratios such as P/E, P/S and P/B, plus the technical analysis further down the page, for the full picture.Is Legence overvalued or undervalued?
Legence is currently undervalued with a gap of 93.6% relative to the price target.
The current price is $52.97, which places Legence in the undervalued category. The stock is considered undervalued when the price is below $92.28, and overvalued when the price exceeds $112.78.
The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For Legence, the fair value range lies between $92.28 and $112.78.
About Legence – Engineering & Construction
Legence Corp. provides engineering, installation, and maintenance services for mission-critical systems in buildings in the United States. The company operates through two segments, Engineering & Consulting, and Installation & Maintenance. The Engineering & Consulting segment designs HVAC and other MEP systems for buildings, develops strategies to help reduce energy usage and make buildings more sustainable and provides program and project management services for client's installation and retrofit projects. This segment also offers engineering & design and program and project management services. The Installation & Maintenance segment fabricates and installs HVAC systems, process piping and other MEP systems in new and existing industrial, commercial and institutional buildings and provides ongoing preventative and corrective maintenance services, emergency repair, and break-fix services, as well as facility energy analysis, automation, optimization, and system certification and testing. It serves data centers, technology, life sciences, healthcare, education, mixed-use, state and local government, and other markets. The company was founded in 1914 and is based in San Jose, California. Read more about the companyKey Figures for Legence
What kind of stock is Legence?
Legence is classified as a speculative stock.
Score Overview for Legence
📈 Valuation
The P/S ratio is 2.3. The P/B ratio is 6.7.
💵 Profitability & Growth
Legence and an operating margin of 2.8%. Return on assets (ROA) is 2.3%.
🏦 Financial Health
The Piotroski score is 5 out of 9 — average financial health. Altman Z2 is 0.79 (weak balance sheet — elevated risk). The debt-to-equity ratio (D/E) is 1,060.2% — high debt, which raises the risk.
🚀 Momentum & Short Interest
Short interest is 5.61% — elevated, some investors are betting on a decline.
Legence Short Selling 2026: 5.6% Sold Short
What does this mean for you as an investor?
A short interest of 5.6% means that 5.6% of the freely traded shares in Legence have been borrowed and sold by investors betting on falling prices.
Data is updated daily based on official filings with the SEC.
When Does Legence Report Earnings?
The next earnings date for Legence is not yet available. Check the company's investor calendar for more information.Technical Analysis of Legence 2026 – Signal: Sell
Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated September 8, 2026.
Trend Analysis of Legence Corp. Class A Common stock
Legence Corp. Class A Common stock is in a short-term downtrend. The price of $52.97 is 10.8% below the 20-day average ($59.41). Medium term, the picture is negative: the price is 19.6% below the 50-day average ($65.85). Long term, the stock is 15.3% below the 200-day average ($62.51), which signals a long-term downtrend.
Golden Cross: The 50-day average (65.85) is above the 200-day average (62.51), which is a classic bullish signal for Legence Corp. Class A Common stock.
Is Legence Corp. Class A Common stock overbought or oversold?
Legence Corp. Class A Common stock has an RSI of 36.2. The stock sits in the lower part of the neutral zone, which points to weak momentum without being oversold. In the current downtrend, be careful about reading this as a buying opportunity.
MACD Analysis for Legence Corp. Class A Common stock
Daily MACD: MACD is negative (-4.130), which means the short-term trend is bearish (the 12-day EMA is below the 26-day EMA). MACD is below the signal line (-3.713) by 0.417, which confirms growing negative momentum in the downtrend.
Weekly MACD: MACD5 is positive (0.010), which indicates a broader bullish long-term trend. MACD5 is below the signal line (4.661) by 4.651, which suggests the long-term momentum is fading – the positive trend could come under pressure.
Overall MACD assessment: The daily and weekly MACD give conflicting signals. The long-term trend is bullish, but the short-term trend is bearish. Short-term momentum is still falling – a deeper pullback is possible.
Risk Profile for Legence Corp. Class A Common stock
Legence Corp. Class A Common stock has an annual standard deviation of 72.5%, which classifies the stock as Extremely speculative. Only risk-tolerant investors should consider this stock, because the price swings can be very large.
Overall Technical Conclusion for Legence Corp. Class A Common stock
Trend: Negative. The price trades below SMA50 and SMA200.
MACD trend (zero line): Daily bearish (-4.130). Weekly bullish (0.010).
MACD momentum (signal): Daily falling. Weekly falling.
RSI: 36.2 – neutral.
Technical signal: Sell
The trend is negative and MACD is below the zero line, which confirms the bearish momentum. Consider reducing the position or setting a stop-loss.